「日本人の食事摂取基準(2025年版)」策定検討会報告書 (410 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
出典情報 | 「日本人の食事摂取基準(2025年版)」策定検討会報告書(10/11)《厚生労働省》 |
ページ画像
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2.
59) da Silva LSL, Abdalla PP, Marcos-Pardo PJ, et al. Sarcopenic obesity does not impair lower limb strength
and physical performance in sufficiently active older adults: a cross-sectional study. Sci Rep.
2024;14(1):3061.
60) Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN
and EASO consensus statement. Obes Facts. 2022;15(3):321-335.
61) Prado CM, Batsis JA, Donini LM, et al. Sarcopenic obesity in older adults: a clinical overview. Nat Rev
Endocrinol. 2024;20(5):261-277.
62) Hsu KJ, Liao CD, Tsai MW, et al. Effects of exercise and nutritional intervention on body composition,
metabolic health, and physical performance in adults with sarcopenic obesity: A meta-analysis. Nutrients.
2019;11(9):2163.
63) Umegaki H. Sarcopenia and frailty in older patients with diabetes mellitus: Sarcopenia and frailty in DM.
Geriatr Gerontol Int. 2016;16(3):293-299.
64) 荒井秀典. フレイルの意義. 日本老年医学会雑誌. 2014;51(6):497-501.
65) Angulo J, El Assar M, Rodríguez-Mañas L. Frailty and sarcopenia as the basis for the phenotypic
manifestation of chronic diseases in older adults. Mol Aspects Med. 2016;50:1-32.
66) Xue QL, Bandeen-Roche K, Varadhan R, et al. Initial manifestations of frailty criteria and the development
of frailty phenotype in the Women’s Health and Aging Study II. J Gerontol A Biol Sci Med Sci.
2008;63(9):984-990.
67) Cruz-Jentoft AJ, Kiesswetter E, Drey M, et al. Nutrition, frailty, and sarcopenia. Aging Clin Exp Res.
2017;29(1):43-48.
68) Artaza-Artabe I, Sáez-López P, Sánchez-Hernández N, et al. The relationship between nutrition and frailty:
Effects of protein intake, nutritional supplementation, vitamin D and exercise on muscle metabolism in the
elderly. A systematic review. Maturitas. 2016;93:89-99.
69) Porter Starr KN, McDonald SR, Bales CW. Obesity and physical frailty in older adults: a scoping review of
lifestyle intervention trials. J Am Med Dir Assoc. 2014;15(4):240-250.
70) Nishida Y, Yamada Y, Sasaki S, et al. Effect of overweight/obesity and metabolic syndrome on frailty in
middle-aged and older Japanese adults. Obes Sci Pract. 2024;10(1):e714.
71) Nguyen TN, Nguyen TN, Nguyen AT, et al. Appendicular lean mass and frailty among geriatric outpatients.
J Frailty Aging. 2022;11(2):177-181.
72) Watanabe D, Yoshida T, Watanabe Y, et al. A U-shaped relationship between the prevalence of frailty and
body mass index in community-dwelling Japanese older adults: The Kyoto-Kameoka study. J Clin Med.
2020;9(5).
73) Yuan S, Larsson SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism.
2023;144(155533):155533.
74) Sieber CC. Malnutrition and sarcopenia. Aging Clin Exp Res. 2019;31(6):793-798.
75) Choi KM. Sarcopenia and sarcopenic obesity. Korean J Intern Med. 2016;31(6):1054-1060.
76) Watanabe D, Yoshida T, Watanabe Y, et al. Frailty modifies the association of body mass index with
mortality among older adults: Kyoto-Kameoka study. Clin Nutr. 2024;43(2):494-502.
400